Intrapatient Dose Escalation of Anti–CTLA-4 Antibody in Patients With Metastatic Melanoma

We previously reported our experience in treating 56 patients with metastatic melanoma using a human anti-cytotoxic T-lymphocyte antigen 4 (CTLA-4) antibody. Durable tumor regressions were seen that correlated with the induction of autoimmune toxicities. In this study, we treated 46 additional patie...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Maker, Ajay V., Yang, James C., Sherry, Richard M., Topalian, Suzanne L., Kammula, Udai S., Royal, Richard E., Hughes, Marybeth, Yellin, Michael J., Haworth, Leah R., Levy, Catherine, Allen, Tamika, Mavroukakis, Sharon A., Attia, Peter, Rosenberg, Steven A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2006
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2134804/
https://ncbi.nlm.nih.gov/pubmed/16799341
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/01.cji.0000208259.73167.58
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados